Givinostat Slows Duchenne Muscular Dystrophy Decline
Givinostat (Duvyzat) slowed physical decline as measured by stair climbing speed for a subset of boys with Duchenne muscular dystrophy (DMD), according to the phase III trial that supported the drug’s recent approval for this indication. While the boys still declined over 72 weeks on the oral drug, their times for a four-stair climb assessment […]